Covered recipient · General Payments record
ANTHONY DE LILLO
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$7,409.52
- Reported across 398 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,475.77 | 78 |
| Long term medical supply or device loan | $193.55 | 1 |
| Education | $15.02 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $351.89 | 16 |
| PENTAX OF AMERICA, INC. | $193.55 | 1 |
| GENZYME CORPORATION | $118.76 | 6 |
| PFIZER INC. | $110.54 | 7 |
| Lilly USA, LLC | $108.83 | 6 |
| Novo Nordisk AS | $107.31 | 6 |
| Janssen Biotech, Inc. | $105.96 | 6 |
| Takeda Pharmaceuticals U.S.A., Inc. | $84.16 | 5 |
| Corcept Therapeutics | $73.85 | 3 |
| Asensus Surgical, Inc. | $44.81 | 1 |
| Phathom Pharmaceuticals, Inc. | $42.89 | 3 |
| Ardelyx, Inc. | $35.74 | 2 |
| Medtronic, Inc. | $32.10 | 1 |
| GlaxoSmithKline, LLC. | $28.48 | 2 |
| DePuy Synthes Sales Inc. | $22.53 | 1 |
| Cleerly, Inc. | $19.50 | 1 |
| Celgene Corporation | $16.91 | 1 |
| Ferring Pharmaceuticals Inc. | $16.61 | 1 |
| Regeneron Healthcare Solutions, Inc. | $16.50 | 1 |
| Fresenius Kabi USA, LLC | $16.45 | 1 |
| IBSA Pharma Inc. | $16.32 | 1 |
| Amgen Inc. | $16.18 | 1 |
| Kyowa Kirin, Inc. | $15.93 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.63 | 1 |
| Echosens North America, Inc. | $15.30 | 1 |
| Celltrion USA Inc. | $15.02 | 1 |
| Gilead Sciences, Inc. | $14.99 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $14.10 | 1 |
| Xeris Pharmaceuticals, Inc. | $13.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (80)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.